Only logged in customers who have purchased this product may leave a review.
UBC Chemo AAA+
$10.00 – $200.00
This is a one of a kind strain that is heavy-hitting. Many smokers report a feeling of relaxation, couch-lock, and restful sleep. The effects begin with a sense of bliss and euphoria that is key in melting away stress and tension. UBC Chemo is essential for those looking to manage pain, stress, lack of appetite, insomnia, and anxiety.
Canada is known for its craft cannabis strains that are world-renowned for their potency, taste, and smell. This strain is very quickly gaining popularity and as the name suggests, it was born and bred in British Columbia. Although the genetics of this strain are shrouded in mystery, it is widely believed that geneticist David Suzuki had a hand in creating this strain during the late 60s and early 70s.
Dr. Suzuki had a vision to create a strain that would be beneficial in easing the suffering of cancer patients from the adverse effects of chemotherapy. This strain gained popularity when it began to be cultivated by Jordan of the Islands. The THC content is impressive with some yields reaching as high as 29%.
This is a one of a kind strain that is heavy-hitting. Many smokers report a feeling of relaxation, couch-lock, and restful sleep. The effects begin with a sense of bliss and euphoria that is key in melting away stress and tension. UBC Chemo is essential for those looking to manage pain, stress, lack of appetite, insomnia, and anxiety.
The bud structure is very unique in the sense that many tend to have a bonsai-like appearance, with medium to large sized buds that are very dense in structure. The bouquet is described as floral, with notes of spicy chocolate. The taste is reminiscent of milk chocolate, hibiscus, and cinnamon.
A sweet treat, indeed.
24-29% THC
Flavours: Chocolate, Spice, Floral, Earthy
Effects: Euphoric, Sleepy, Relaxed, Calm
Medical Uses: PTSD, Anxiety, Depression, Chronic Pain, Inflammation, Muscle Spasms.
1 review for UBC Chemo AAA+
There are no reviews yet.